Accessibility issues in cancer care

Research identifies issues with booking new appointments at clinics for cancer treatment

3:48 PM

Author | Tessa Roy

cancer cell blue yellow
Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their first phone call to a clinic. 

Patients attempting to access cancer care must go through several different levels of communication, both before their initial appointment with a physician and throughout their treatment. 

Making those first calls to learn more about available cancer care services or to schedule an appointment at a clinic is an important step toward beginning their treatment journey.  

“Racial and ethnic disparities have been observed in the outpatient visit rates for specialist care, including cancer care. However, we know very little about patients’ experiences at the critical step of attempting to access new clinic appointments for cancer care,” said Debbie Chen, M.D. 

Researchers set up simulated patient calls and studied whether each caller was able to access cancer care – that meant whether the caller was provided with a clinic appointment date or scheduling information. 

Using standardized scripts, the simulated patients spoke in one of three languages – English, Spanish, or Mandarin – and inquired about a new clinic appointment for colon, lung, or thyroid cancer care. 

The simulated patients called 479 clinic phone numbers, which were provided by the hospital general information staff at 143 hospitals in 12 states.  

Researchers found that access to new patient appointments for cancer care was poor for all simulated patient callers in the study – only 41.5% of the 985 total calls were successful. 

Even the simulated English-speaking patient caller encountered challenges and were successful in accessing cancer care in only 61% of calls. 

About one-quarter of the 985 calls ended early due to workflow barriers, which included calls going to a voicemail that did not provide adequate information, or being on hold for over half an hour.  

In addition, researchers found that access to new patient appointments for cancer care was worse for non-English speaking patients. 

The simulated Spanish- and Mandarin- speaking patient callers accessed cancer care in only 36% and 19% of the calls, respectively, far less than their English-speaking counterpart. 

Nearly 50% of the calls made in Spanish or Mandarin ended due to language barriers when simulated patient callers were hung up on in response to asking “Speak Spanish?” or “Speak Chinese?”, or disconnected when the automated message did not provide language-specific instructions but required input to continue. 

Even after getting connected to interpreter services, some callers were unable to receive further assistance.  

"Our study highlights existing barriers that patients may encounter when attempting to access a new clinic appointment for cancer care and illustrates how this access point functions as a gatekeeper to cancer care services, with many patient populations, including patients with limited English proficiency, unable to even get in the door to see a physician for their cancer care” Chen said. 

Thus, interventions focused on mitigating these barriers are necessary to increase access to cancer care for all patients.

This study was supported by the University of Michigan Rogel Cancer Center (Discovery Award to Dr Chen), National Institute of Diabetes and Digestive and Kidney Diseases (grant No. T32DK007245 to Dr Chen), and National Cancer Institute (grant No. K08CA273047 to Dr Chen).

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Paper cited: “Access to New Clinic Appointments for Patients With Cancer,” JAMA. DOI: 10.1001/jamanetworkopen.2024.15587

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: Cancer Research All Research Topics Cancer Care
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories doctor close up listening to baby's heart while baby touches stethoscope while doctor smiles in doctor exam room on exam room table with medical equipment in background
Health Lab
Commentary: Employers are failing to insure the working class – Medicaid cuts will leave them even more vulnerable
A physician talks about what Medicaid cuts will impact Americans across the country.
breathing tube in patient close up in hospital bed
Health Lab
Removal of ventilator breathing tube is delayed for some patients, posing health risks
A study by Michigan Medicine determined how many patients who pass spontaneous breathing trials were extubated within six hours and what factors were associated with staying connected to a ventilator.
yellow pills spilling out of bottle
Health Lab
Study sheds light on why some prostate tumors are resistant to treatment
A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. 
History map
News Release
From the Diag to the world: 175 years of U-M medical history
An interactive map and article that trace the history of Michigan Medicine
pink cells up close
Health Lab
Research links iron-mediated cell death and inflammatory bowel disease
New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.
two foxes on grass
Health Lab
Study reveals mechanisms behind common mutation and prostate cancer
A study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.